Patents by Inventor Ai-Ping Wei
Ai-Ping Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140370535Abstract: A sterility indicating composition comprising a plurality of sterilization process resistant spores which contain an active protease during germination and initial outgrowth of the spores; and a germination medium comprising at least one labeled protease substrate and at least one nutrient for germination of the spores; wherein the medium is essentially free of a) any active protease other than the active protease contained by the plurality of spores and b) any protease substrate other than the at least one labeled protease substrate, other than any protease substrate originating from the plurality of spores, and other than any protease substrate which does not compete with the labeled protease substrate for the active protease; and wherein the at least one labeled protease substrate comprises a peptide which can be cleaved by the active protease and which is labeled with one or more dye groups, at least one of which undergoes a detectable change when the peptide is cleaved by the active protease, and whereinType: ApplicationFiled: August 28, 2014Publication date: December 18, 2014Inventors: SAILAJA CHANDRAPATI, HEATHER M. WEBB, AI-PING WEI
-
Publication number: 20140335543Abstract: The present invention provides antibodies that bind to the endospore of the bacterium Clostridium difficile, methods of making such antibodies, and methods of using such antibodies, including methods of detecting C. difficile endospores.Type: ApplicationFiled: March 12, 2014Publication date: November 13, 2014Applicant: 3M Innovative Properties CompanyInventors: RAJ RAJAGOPAL, AI-PING WEI
-
Patent number: 8697374Abstract: The present invention provides antibodies that bind to the endospore of the bacterium Clostridium difficile, methods of making such antibodies, and methods of using such antibodies, including methods of detecting C. difficile endospores.Type: GrantFiled: February 25, 2009Date of Patent: April 15, 2014Assignee: 3M Innovative Properties CompanyInventors: Raj Rajagopal, Ai-Ping Wei
-
Patent number: 8325345Abstract: Herein are disclosed methods and devices for evaluating the quality of oils (e.g., cooking oil or flying oil). The methods can provide an indication of the free fatty acid content of the oil. The methods use an optical interrogation device to provide an indication of free fatty acid based on quantitative measurements of optical reflectance from test zones on a sampling substrate.Type: GrantFiled: March 2, 2009Date of Patent: December 4, 2012Assignee: 3M Innovative Properties CompanyInventors: Abolghassem B. Mahmoodi, Milind Balwant Sabade, Ai-Ping Wei
-
Patent number: 8257976Abstract: Herein are disclosed methods and devices for optically monitoring multiple parameters of an oil sample. In one embodiment, the methods and devices can be used for determining the quality of cooking or flying oil in terms of the free fatty acid content and total polar compound content of the oil. The methods use an optical absorbtive/reflective property in evaluating the free fatty acid content, and use optical fluorescence in evaluating the total polar compound content, with both measurements using a single sampling substrate and a single measuring device.Type: GrantFiled: March 2, 2009Date of Patent: September 4, 2012Assignee: 3M Innovative Properties CompanyInventors: Ai-Ping Wei, Milind Balwant Sabade, Abolghassem B. Mahmoodi
-
Publication number: 20110195442Abstract: A sterility indicating composition comprising a plurality of sterilization process resistant spores which contain an active protease during germination and initial outgrowth of the spores; and a germination medium comprising at least one labeled protease substrate and at least one nutrient for germination of the spores; wherein the medium is essentially free of a) any active protease other than the active protease contained by the plurality of spores and b) any protease substrate other than the at least one labeled protease substrate, other than any protease substrate originating from the plurality of spores, and other than any protease substrate which does not compete with the labeled protease substrate for the active protease; and wherein the at least one labeled protease substrate comprises a peptide which can be cleaved by the active protease and which is labeled with one or more dye groups, at least one of which undergoes a detectable change when the peptide is cleaved by the active protease, and whereinType: ApplicationFiled: October 15, 2009Publication date: August 11, 2011Inventors: Sailaja Chandrapati, Heather M. Webb, Ai-Ping Wei
-
Publication number: 20110183360Abstract: The present invention provides antibodies that bind to the endospore of the bacterium Clostridium difficile, methods of making such antibodies, and methods of using such antibodies, including methods of detecting C. difficile endospores.Type: ApplicationFiled: February 25, 2009Publication date: July 28, 2011Inventors: Raj Rajagopal, Ai-Ping Wei
-
Publication number: 20110059532Abstract: Herein are disclosed methods and devices for optically monitoring multiple parameters of an oil sample. In one embodiment, the methods and devices can be used for determining the quality of cooking or flying oil in terms of the free fatty acid content and total polar compound content of the oil. The methods use an optical absorbtive/reflective property in evaluating the free fatty acid content, and use optical fluorescence in evaluating the total polar compound content, with both measurements using a single sampling substrate and a single measuring device.Type: ApplicationFiled: March 2, 2009Publication date: March 10, 2011Inventors: Ai-Ping Wei, Milind Balwant Sabade, Abolghasssen B. Mahmoodi
-
Publication number: 20110051141Abstract: Herein are disclosed methods and devices for evaluating the quality of oils (e.g., cooking oil or flying oil). The methods can provide an indication of the free fatty acid content of the oil. The methods use an optical interrogation device to provide an indication of free fatty acid based on quantitative measurements of optical reflectance from test zones on a sampling substrate.Type: ApplicationFiled: March 2, 2009Publication date: March 3, 2011Inventors: Abolghassem B. Mahmoodi, Milind Balwant Sabade, Ai-Ping Wei
-
Publication number: 20100260903Abstract: A method of determining the quality of oil by irradiating the oil at a first wavelength, e.g., of about 470 nm, measuring a level of fluorescence of the oil at a second wavelength, e.g., of about 520 nm, comparing the measured fluorescence level to a predetermined threshold level to determine whether or not the oil quality is acceptable. The oil is preferably discarded if the measured fluorescence level exceeds the predetermined threshold level, which can be generally dependent on the oil composition. The fluorescence is correlated to the level of polar components in the oil. Also described are devices for determining the quality of oil via fluorescence.Type: ApplicationFiled: January 4, 2008Publication date: October 14, 2010Inventors: Ai-Ping . Wei, Raj Rajagopal, Catherine Bineau
-
Publication number: 20080306252Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.Type: ApplicationFiled: May 30, 2008Publication date: December 11, 2008Applicant: Coley Pharmaceutical Group, Inc.Inventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill, Ralph R. Roberts, Ai-Ping Wei
-
Patent number: 7256012Abstract: A method of biological assay comprises the steps of providing an enzyme substrate comprising two fluorescence dye groups bound to a flexible peptide, the dye groups being of proximity sufficiently close so as to allow free energy attractions to draw the dyes together to essentially self-quench fluorescence of the dye groups, wherein self quenching of fluorescence of the dye groups is effected by dye dimerization or stacking, and enzymatically cleaving the peptide to release the fluorescence dye groups from dye dimerization or stacking, thereby producing an increase in fluorescence intensity. A protease substrate for use in the method of the invention is also disclosed. This invention finds use in detection and identification of microorganisms, sterilization assurance, pharmaceutical discovery, enzyme assays, immunoassays, and other biological assays.Type: GrantFiled: August 31, 2004Date of Patent: August 14, 2007Assignee: 3M Innovative Properties CompanyInventors: Ai-Ping Wei, Michael George Williams
-
Patent number: 7153654Abstract: Fluorescent energy transfer dyes capable of moving between a more stacked configuration to exhibit fluorescent quenching and a more spaced configuration to exhibit fluorescence can be conjugated to a peptide epitope or nucleic acid for use in the detection of an unknown antibody in bulk solution. The resulting labeled peptide reagent can be used in an immunoassay procedure by placing it in bulk solution along with the unknown antibody to be detected. When the antibody binds to the peptide epitope, the pair of dyes carried by the peptide epitope will have their configuration altered from a stacked to an unstacked configuration and will exhibit a fluorescent increase in response thereto.Type: GrantFiled: October 31, 2002Date of Patent: December 26, 2006Assignee: University of Utah Research FoundationInventors: Ai-Ping Wei, James N. Herron
-
Patent number: 7132429Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.Type: GrantFiled: February 28, 2005Date of Patent: November 7, 2006Assignee: 3M Innovative Properties CompanyInventors: George W. Griesgraber, Bryon A. Merrill, Ralph R. Roberts, Ai-Ping Wei
-
Patent number: 6916925Abstract: Dye labeled imidazonaphthyridine, imidazopyridine and imidazoquinoline compounds having immune response modulating activity are disclosed. The compounds arc useful, inter alia, for determining the binding and/or receptor sites of the molecules.Type: GrantFiled: July 22, 2003Date of Patent: July 12, 2005Assignee: 3M Innovative Properties Co.Inventors: Michael J. Rice, Mark A. Tomai, Ai-Ping Wei
-
Publication number: 20050148620Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.Type: ApplicationFiled: February 28, 2005Publication date: July 7, 2005Inventors: Stephen Crooks, George Griesgraber, Philip Heppner, Bryon Merrill, Ralph Roberts, Ai-Ping Wei
-
Publication number: 20050148619Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.Type: ApplicationFiled: February 28, 2005Publication date: July 7, 2005Inventors: Stephen Crooks, George Griesgraber, Philip Heppner, Bryon Merrill, Ralph Roberts, Ai-Ping Wei
-
Publication number: 20050089946Abstract: A method of biological assay comprises the steps of providing an enzyme substrate comprising two fluorescence dye groups bound to a flexible peptide, the dye groups being of proximity sufficiently close so as to allow free energy attractions to draw the dyes together to essentially self-quench fluorescence of the dye groups, wherein self quenching of fluorescence of the dye groups is effected by dye dimerization or stacking, and enzymatically cleaving the peptide to release the fluorescence dye groups from dye dimerization or stacking, thereby producing an increase in fluorescence intensity. A protease substrate for use in the method of the invention is also disclosed. This invention finds use in detection and identification of microorganisms, sterilization assurance, pharmaceutical discovery, enzyme assays, immunoassays, and other biological assays.Type: ApplicationFiled: August 31, 2004Publication date: April 28, 2005Inventors: Ai-Ping Wei, Michael Williams
-
Patent number: 6787329Abstract: A method of biological assay comprises the steps of providing an enzyme substrate comprising two fluorescence dye groups bound to a flexible peptide, the dye groups being of proximity sufficiently close so as to allow free energy attractions to draw the dyes together to essentially self-quench fluorescence of the dye groups, wherein self quenching of fluorescence of the dye groups is effected by dye dimerization or stacking, and enzymatically cleaving the peptide to release the fluorescence dye groups from dye dimerization or stacking, thereby producing an increase in fluorescence intensity. A protease substrate for use in the method of the invention is also disclosed. This invention finds use in detection and identification of microorganisms, sterilization assurance, pharmaceutical discovery, enzyme assays, immunoassays, and other biological assays.Type: GrantFiled: November 24, 1999Date of Patent: September 7, 2004Assignee: 3M Innovative Properties CompanyInventors: Ai-Ping Wei, Michael George Williams
-
Publication number: 20040097542Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.Type: ApplicationFiled: October 29, 2003Publication date: May 20, 2004Applicant: 3M Innovative Properties CompanyInventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill, Ralph R. Roberts, Ai-Ping Wei